Hemosol B0 Norway - Norway - Statens legemiddelverk

hemosol b0

baxter holding b.v. - kalsiumkloriddihydrat / magnesiumkloridheksahydrat / melkesyre / natriumhydrogenkarbonat / natriumklorid - hemodialyse-/hemofiltreringsvæske

Ibandronsyre Medical Valley 150 mg Norway - Norway - Statens legemiddelverk

ibandronsyre medical valley 150 mg

medical valley invest ab - ibandronatnatriummonohydrat - tablett, filmdrasjert - 150 mg

Phoxilium 1,2 mmol/l fosfat Norway - Norway - Statens legemiddelverk

phoxilium 1,2 mmol/l fosfat

baxter holding b.v. - kalsiumkloriddihydrat / dinatriumfosfatdihydrat / magnesiumkloridheksahydrat / natriumklorid / natriumhydrogenkarbonat / kaliumklorid - hemodialyse-/hemofiltreringsvæske

Prismasol 4 mmol/l Kalium Norway - Norway - Statens legemiddelverk

prismasol 4 mmol/l kalium

baxter holding b.v. - kalsiumkloriddihydrat / magnesiumkloridheksahydrat / glukosemonohydrat / melkesyre, (s)- / natriumklorid / kaliumklorid / natriumhydrogenkarbonat - hemodialyse-/hemofiltreringsvæske

Regiocit 18 mmol/ L / 140 mmol/ L Norway - Norway - Statens legemiddelverk

regiocit 18 mmol/ l / 140 mmol/ l

baxter holding b.v. - natriumsitrat / natriumklorid - hemofiltreringsvæske - 18 mmol/ l / 140 mmol/ l

Rozlytrek Kesatuan Eropah - Norway - EMA (European Medicines Agency)

rozlytrek

roche registration gmbh  - entrectinib - cancer; carcinoma, non-small-cell lung - antineoplastiske midler - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.

Aldara 5 % Norway - Norway - Statens legemiddelverk

aldara 5 %

paranova as (1) - imikvimod - krem - 5 %